Douglas Cheung Email & Phone Number

Washington, District Of Columbia, United States

The Office of Management and Budget resides within the Executive Office of the President of the United States. In the Medicaid branch, I focus on budget and policy issues related to eligibility, benefits, prescription drugs, tribes, and interactions with other health and social programs.

Washington, District Of Columbia, United States

Medicaid Branch

Washington, District Of Columbia, United States

• Budget and Performance Policy Branch, Office of Budget,Office of the Assistant Secretary for Financial Resources, Office of the Secretary
• Facilitate senior leadership budget formulation decisions by coordinating with 20+ analysts to produce crosscutting budget data on Administration priority areas within HHS’s $130B+ discretionary and $1.5T+ mandatory.
• Coordinated the production and timely public release of the Fiscal Year 2022 HHS Budget-in-brief and Annual Performance Plan and Report.
• Coordinated and cleared multiple House and Senate Appropriations summary memos for the Secretary with two memos completed within hours.
• Leveraged technology by operationalizing a coediting-enabled collaboration environment that streamlined and increased efficiency of the budget production process across divisions within the Office of Budget.

Washington, District Of Columbia, United States

The PMF Program is a flagship leadership development program for advanced degree candidates who are interested in Federal service. It was established by Executive Order in 1977 and is highly selective with an acceptance rate of 7% (425 out of 6040 applicants selected as finalists) in 2018. PMFs receive formal interactive training on leadership, management.

Washington D.C. Metro Area

• ReImagine HHS Transformation Management Office, Immediately Office of the SecretaryPresident’s Management Agenda (PMA): The management office coordinates activities across HHS related to the PMA, a long-term vision.
• Analyzed and shared insights on data from >450 HHS PMA initiatives with senior executives to facilitate the annual update of the Department’s Enterprise Risk Profile and promote risk-based management decisions.
• Briefed the core team of the Department’s Enterprise Risk Management Community of Practice, which consists of 150+ GS-14/15 staff, on the functions of the PMA team and connections between PMA and the community.
• Provided analysis and recommendations on PMA-related policy and strategy documents, that guided the direction and provided instructions related to the PMA, including the GSA PMA Ramp-Up Volume and the Office of.
• Drove the development of the Department’s AI strategy by assessing and generating a report on HHS’ AI readiness through interviews with Chief Information Officers and stakeholders across the Department.
• Re-designed a dashboard to better capture PMA progress and communicated developments with the Associate Deputy Secretary in bi-weekly meetings. Regulatory Clean-up Initiative: The first government initiative that.

Rockville, Maryland

Please see the description of the PMF Program covered above.

Rockville, Maryland

• Executed ~50 technology transfer agreements with industrial and academic research partners, resulting in multiple clinical trials, including a multi-site glioblastoma trial that involved >10 medical centers and 2.
• Managed intellectual property portfolios of NCI scientists that resulted in 4 executed licenses related to NCI proprietary biological materials with biotech companies.
• Led 2 subgroups within the Invention Evaluation and Implementation Project Team that produced guidance documents to improve existing invention and patent application management process.
• Assisted in the preparation of the NCI Exclusive License Sourcebook that became the standard reference for languages in exclusive license agreements.

Columbus, Ohio Area

• Advised under Professor Carlo M. Croce.
• Studied the feasibility of using a Phase-2 liver cancer drug (a cell cycle dependent kinase inhibitor) in breast cancer in vitro and in vivo, and the role of microRNAs in cancers, resulting in co-authorships in 5.
• Beta-tested a new assay platform developed by Circulomics, a start-up company in Baltimore, Maryland, now acquired by Pacific Biosciences.
• Generated a novel mouse model in collaboration with Dr. Vincenzo Coppola’s laboratory, resulting in new knowledge in microRNA biogenesis and its importance in embryo development.
• Trained and supervised 1 medical student, 1 graduate student, and 4 undergraduate researchers.

Columbus, Ohio Area

• Evaluated invention disclosures for patenting and licensing potential by preparing due diligence reports on market and intellectual property landscapes and identifying potential licensees.
• Prepared non-confidential intellectual property marketing materials to attract potential licensees.
• Assisted licensing managers with licensing contracts and legal actions regarding patent applications.
• Participated in university outreach events to promote technology commercialization awareness.

Columbus, Ohio Area

Advised under Professor Carlo M. Croce. Please see the description under the Post Doctoral Researcher position for accomplishments made during this role.

Greater Seattle Area

• Advised under Professor Miqin Zhang.
• Managed the synthesis and characterization (chemical assays, UV-Vis spectrometry, chromatography, DLS, ICP, and FTIR) of nanoparticles for downstream use in cancer drug delivery and imaging research.
• Trained and supervised 2 undergraduate researchers.

Ph.D., Molecular, Cellular And Developmental Biology

B.S., Bioengineering